AIC
INDV icon

AWM Investment Company’s Indivior Pharmaceuticals INDV Stock Holding History

AWM Investment Company’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,605
Closed -$2.71M – 107
2025
Q4 		$2.71M Hold
75,605
– – 0.26% 81
2025
Q3 		$1.82M Buy
+75,605
New +$1.58M 0.17% 87

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AWM Investment Company's INDV Position: Q1 2026 in Review

AWM Investment Company sold out of Indivior Pharmaceuticals (INDV) in Q1 2026, closing a stake of 75,605 shares — an estimated $2.71M sold.

AWM Investment Company first reported a position in INDV in Q3 2025 and held it in 2 quarters. The position peaked at $2.71M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • AWM Investment Company reported no remaining Indivior Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AWM Investment Company sold 75,605 Indivior Pharmaceuticals shares in Q1 2026, an estimated $2.71M.
  • AWM Investment Company first reported a position in Indivior Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • AWM Investment Company's Indivior Pharmaceuticals position peaked at $2.71M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.